A rare case of Duodenal cancer with Achalasia cardia
AbstractDuodenal adenocarcinoma constitutes 0.4% of gastrointestinal malignancies. Achalasia incidence rate is 0.5-1.2 per 100000. The combination is rare.
This is a report of a 68-year-old male from Nepal with history of five years abdominal pain, dysphasia and weight loss. Duodenoscopy could confirm ulcero-proliferative growth at D1-D2. Barium meal depicted features of achalasia cardia.
No similar case report suggests that occurrence of duodenal carcinoma and achalasia cardia is merely co- incidental.
Discussion: No similar case report suggests that occurrence of duodenal carcinoma and achalasia cardia is merely co- incidental.
Consent: Informed consent was obtained from the patient for publication of this case report .
2. Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999 Dec 15;86(12):2693-706.
3. Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg. 1998 Jan-Feb;2(1):79-87.
4. O'Neill OM1, Johnston BT, Coleman HG. Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2013 Sep 21;19(35):5806-12.
5. Cunningham JD1, Aleali R, Aleali M, Brower ST, Aufses AH. Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg. 1997 Mar;225(3):300-6.
6. Lillemoe K, Imbembo AL. Malignant neoplasms of the duodenum. Surg Gynecol Obstet. 1980 Jun;150(6):822-6.
7. Fagniez PL, Rotman N. Malignant tumors of the duodenum. In: Holzheimer RG, Mannick JA, editors. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6953/
8. Bitik B, Kalpakci Y, Altan E, Dogan E, Altundag K. Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen. Ann Oncol. 2009 Feb;20(2):394-5.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
JSSN applies the Creative Commons Attribution (CC BY) license to all works we publish. Under the CC BY license, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, distribute, and/or copy articles in JSSN, so long as the original authors and source are cited. No permission is required from the authors or the publishers.
Article by JSSN is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://www.jssn.org.np/index.php?journal=jssn.